Demonstrating its ongoing commitment to data security and operational excellence, Isomerase has successfully achieved the ISO 27001:2022 certification; the internationally recognized standard for information security management systems (ISMS).
This milestone reflects the company’s proactive approach to safeguarding client data, protecting intellectual property, and managing risk across its scientific and business operations. The ISO 27001 certification was awarded following a rigorous independent audit, confirming that Isomerase has implemented comprehensive controls to ensure the confidentiality, integrity, and availability of critical information.
The certification covers a wide scope, ensuring robust protocols are in place for access control, employee awareness, system monitoring, risk assessment, and incident response. It also aligns with industry expectations and regulatory requirements, positioning Isomerase as a reliable and secure partner.
This latest certification adds to Isomerase's impressive portfolio of industry-recognized standards. In addition to ISO 27001 for information security, Isomerase holds ISO 9001 certification for quality management, demonstrating a structured approach to delivering reliable, high-quality outcomes. The company has also been awarded the EcoVadis Gold Medal, placing it in the top 5% of companies globally for sustainability, ethics, human rights, and labor practices.
"I am incredibly proud that Isomerase has officially added ISO 27001 to its growing list of certifications. This shows that not only do we provide our customers with quality products and services (ISO 9001) in a sustainable and ethical manner (EcoVadis Gold Medal) but confirms that we also treat all data with the utmost care and attention for ourselves and our clients. Being accredited with the internationally-recognized ISO 27001 Standard gives those who work with us an added layer of confidence that their sensitive information is safe with us and demonstrates Isomerase’s commitment to ever improving Quality within the company." said Dr. Anna Stanley-Smith, VP of Chemistry, Quality & IT at Isomerase.
These achievements reflect Isomerase's dedication to secure, ethical, and sustainable innovation. We're proud to always set new standards and continue to strive for excellence in all that we do.
About Isomerase
Isomerase is a fully integrated provider of synthetic biology services, encompassing all aspects of microbial product and process discovery and development. We offer advanced solutions in enzyme and microbial process discovery, ensuring a seamless transition from discovery to scalable development. Through our innovative approaches and responsible practices, Isomerase Therapeutics Ltd aims to unlock biotechnology for our clients while making a positive impact on the environment and society.